stockrowProgyny, Inc.
PGNY Healthcare Healthcare Plans
Progyny, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.3 billion, up 10.4% from fiscal 2024.
- Revenue
- +8.91%
- EPS
- +115.3%
- Free cash flow
- +2.72%
Quarter to September 2026, against a year earlier
Follow PGNY
Alert me
Progyny, Inc. (PGNY) EPS (diluted)
Progyny, Inc.'s EPS (diluted) for fiscal 2025 was $0.65, up 14.0% from $0.57 in fiscal 2024. Over the twelve months to 30 September 2026 it was $1.09. Over the past ten years it has ranged from −$2.19 (fiscal 2017) to $0.66 (fiscal 2021); the current reading is higher than 89% of that period. Progyny, Inc. ranks 8th of 12 Healthcare Plans companies by EPS (diluted).
EPS (diluted), annual
Embed this chart
Annual newest first
| Period | EPS (diluted) | Change |
|---|---|---|
| FY2025 | $0.65 | 14.04% |
| FY2024 | $0.57 | (8.06%) |
| FY2023 | $0.62 | 106.67% |
| FY2022 | $0.30 | (54.55%) |
| FY2021 | $0.66 | 40.43% |
| FY2020 | $0.47 | — |
| FY2019 | −$0.41 | — |
| FY2018 | $0.12 | — |
| FY2017 | −$2.19 | — |
Quarterly newest first
| Period | EPS (diluted) | Change |
|---|---|---|
| Sep 2026 | $0.32 | (4.88%) |
| Jun 2026 | $0.34 | 17.24% |
| Mar 2026 | $0.29 | 107.14% |
| Dec 2025 | $0.14 | (6.67%) |
| 28 more quarters | Free account |
Against its own ten years
EPS (diluted) against peers
| Company | EPS (diluted) |
|---|---|
| CI Cigna Group compare | $23.63 |
| ELV Elevance Health, Inc. compare | $23.45 |
| HUM Humana Inc. compare | $10.28 |
| CNC Centene Corporation compare | $2.93 |
| OSCR Oscar Health, Inc. compare | $2.42 |
| PGNY Progyny, Inc. | $1.09 |
| ALHC Alignment Healthcare, Inc. compare | $0.13 |
| CLOV Clover Health Investments, Corp. compare | −$0.05 |
| MOH Molina Healthcare, Inc compare | −$0.96 |
What EPS (diluted) is
Diluted EPS tells an investor how much profit a company earned for each share, counting the extra shares that options and convertible securities could create.
Reported line item
More on PGNY
- Revenue
- Net income
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement